Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer.

@article{Spratt2014ComparisonOH,
  title={Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer.},
  author={Daniel E Spratt and Zachary S Zumsteg and Pirus Ghadjar and Marisa A. Kollmeier and Xin Pei and Gilad Cohen and William Polkinghorn and Yoshiya Yamada and Michael J Zelefsky},
  journal={BJU international},
  year={2014},
  volume={114 3},
  pages={360-7}
}
OBJECTIVE To compare tumour control and toxicity outcomes with the use of high-dose intensity-modulated radiation therapy (IMRT) alone or brachytherapy combined with IMRT (combo-RT) for patients with intermediate-risk prostate cancer. PATIENTS AND METHODS Between 1997 and 2010, 870 consecutive patients with intermediate-risk prostate cancer were treated at our institution with either 86.4 Gy of IMRT alone (n = 470) or combo-RT consisting of brachytherapy combined with 50.4 Gy of IMRT (n = 400… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS
41 Extracted Citations
26 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 41 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 26 references

boost in a modern cohort of intermediate - risk prostate cancer patients

  • GA Viani, EJ Stefano, SL Afonso
  • 2013

A comparison of the impact

  • MA Kollmeier, X Pei, E Algur
  • Radiat Oncol Biol Phys
  • 2012

and external beam radiation therapy for clinically localized prostate cancer

  • R Kotecha, Y Yamada, X Pei
  • 2012

and external beam radiotherapy in the management of clinically localized prostate cancer

  • O Marina, GS Gustafson, LL Kestin
  • 2012

Similar Papers

Loading similar papers…